false 0000806517 0000806517 2024-12-10 2024-12-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 10, 2024

_________________

 

PSYCHEMEDICS CORPORATION

(Exact name of Registrant as Specified in its Charter)

 

Delaware   1-13738   58-1701987
(State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)

 

5220 Spring Valley Road, Suite 230

Dallas, Texas

   75254
(Address of Principal Executive Offices)   (Zip Code)

 

(800) 527-7424

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General instructions A.2. below):

 

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock. $0.005 par value per share   PMD   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 8.01. Other Events.

 

On December 3, 2024, Psychemedics Corporation (the “Company”) closed the transactions contemplated by the previously announced stock purchase agreement, by and among the Company, 3K Limited Partnership, a Delaware limited partnership (“3K”), Peter H. Kamin, the Peter H. Kamin Revocable Trust dated February 2003, the Peter H. Kamin Childrens Trust dated March 1997, the Peter H. Kamin GST Trust and the Peter H. Kamin Family Foundation, pursuant to which 3K purchased 1,409,712 shares of the Company’s common stock at a purchase price of $2.35 per share based on available estimates of the funds required for the Company to purchase all of the fractional share interests that resulted from the Company’s previously announced reverse stock split of its common stock, and thereafter, the Company repurchased on December 10, 2024 320,708 of such shares of common stock from 3K at the same price once confirmation of the total required funds was available from the Company’s transfer agent. 3K provided the Company sufficient funds to purchase all of the fractional share interests that resulted from the reverse stock split and $500,000 for working capital and general corporate purposes.

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PSYCHEMEDICS CORPORATION
Date:  December 10, 2024    
  By:   /s/ Brian Hullinger
  Name:   Brian Hullinger
  Title:   President and Chief Executive Officer

 

 

 

 

v3.24.3
Cover
Dec. 10, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 10, 2024
Entity File Number 1-13738
Entity Registrant Name PSYCHEMEDICS CORPORATION
Entity Central Index Key 0000806517
Entity Tax Identification Number 58-1701987
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 5220 Spring Valley Road
Entity Address, Address Line Two Suite 230
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75254
City Area Code (800)
Local Phone Number 527-7424
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock. $0.005 par value per share
Trading Symbol PMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Psychemedics Charts.
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Psychemedics Charts.